Updated:
IMMAGE BIOTHERAPEUTICS CORP.
IMMAGE BIOTHERAPEUTICS CORP. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001564273, and its reported...
Overview
IMMAGE BIOTHERAPEUTICS CORP. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001564273, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-12-08, it reported net income of USD -216,476; total assets of USD 243,104 for the fiscal period ended 2016-08-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- IMMAGE BIOTHERAPEUTICS CORP.
- Former names in filing history
- EPICURE CHARCOAL, INC. (2012-12-10 to 2015-05-15)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Bethesda, MD, United States
- Incorporated in
- NV
- Fiscal year end
- August 31
- SEC CIK
- 0001564273
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2016USD | -$216,476 | $243,104 | $196,715 | — | |
| FY2015USD | -$18,555 | $2,342 | $2,342 | -$17,614 | |
| FY2013USD | -$12,011 | $7,215 | $7,215 | -$11,861 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research IMMAGE BIOTHERAPEUTICS CORP. in Altss
Track this company’s investors, transactions and relationships in Altss.